Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alteon (ALT) -- Ignore unavailable to you. Want to Upgrade?

To: The Gambler who wrote (219)	3/1/1998 8:35:00 AM
From: Bill Tomko	Read Replies (2) \| Respond to of 318

I'm not ed, but my best GUESS is sideways trading until the last interium Action I review is released in March or April Then depending on the data if favorable, study continues, sideways with a upward bias. If the study were to be terminateted, IMO unlikely, then the stock price declines very much. After the March April review release the only thing that will dirve the stock price, other then overal market, is news,i.e. final action results this summer ( July Aug) ESRD interium report, new clinical trial started, Idexx Lab. vet. filing, FDA filing on Action I clinical (dec98--Mar 99)